Theranostics 2020, Vol. 10, Issue 20 9083 Ivyspring International Publisher Theranostics 2020; 10(20): 9083-9099. doi: 10.7150/thno.46467 Research Paper Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway Hui-Juan Liu1,2*, Yuan Qin1,2*, Zi-Han Zhao1,2*, Yang Zhang4*, Jia-Huan Yang1,2, Deng-Hui Zhai1,2, Fang Cui1,2, Ce Luo1, Man-Xi Lu1, Piao-Piao Liu1, Heng-Wei Xu1,2, Kun Li1,2, Bo Sun2, Shuang Chen2, Hong-Gang Zhou1, Cheng Yang1,2 and Tao Sun1,2,3 1. State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China. 2. Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China. 3. Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin Institute of Digestive Disease, Tianjin, China. 4. Department of Anesthesiology, Tianjin Fourth Central Hospital, Tianjin, China. *These authors have contributed equally to this work. Corresponding authors: Tao Sun, E-mail:
[email protected]; Cheng Yang, E-mail:
[email protected]; Hong-gang Zhou, E-mail:
[email protected]; Hui-juan Liu, E-mail:
[email protected]. © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2020.03.29; Accepted: 2020.06.26; Published: 2020.07.11 Abstract Rationale: Malignant ascites caused by cancer cells results in poor prognosis and short average survival time.